We are creating an entirely new Generation of Precision Medicine against Genetically Defined Diseases.
Location: United States, California, Redwood City
Employees: 11-50
Total raised: $56M
Founded date: 2017
Investors 3
| Date | Name | Website |
| 20.02.2021 | Logos Capi... | logoscapit... |
| 07.07.2021 | Aisling Ca... | aislingcap... |
| 10.02.2022 | MBC BioLab... | mbcbiolabs... |
Funding Rounds 1
| Date | Series | Amount | Investors |
| 06.01.2021 | Series A | $56M | - |
Mentions in press and media 4
| Date | Title | Description |
| 01.07.2024 | BMEA ANNOUNCEMENT: If You Have Suffered Losses in Biomea Fusion, Inc. (NASDAQ: BMEA), You Are Encouraged to Contact The Rosen Law Firm About Your Rights | NEW YORK, July 1, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Biomea Fusion, Inc. (NASDAQ: BMEA) resulting from allegations t... |
| 24.06.2024 | BMEA Investors Have Opportunity to Lead Biomea Fusion, Inc. Securities Fraud Lawsuit | NEW YORK, June 24, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Biomea Fusion, Inc. (NASDAQ: BMEA) resulting from allegations ... |
| 06.03.2024 | Biomea Fusion Presents Patient Cohorts in COVALENT-111 Displaying a Durable Placebo-Adjusted Mean Reduction of up to 1.4% in HbA1c While Off Therapy at Week-26, after BMF-219’s 28-Day Treatment Cycle,... | - |
| 06.01.2021 | Biomea Fusion Raises $56 Million Series A | REDWOOD CITY, Calif.--(BUSINESS WIRE)--Biomea Fusion, Inc., a precision oncology company dedicated to developing innovative medicines targeting genomically defined alterations in both hematologic and solid cancers, announced the closing of ... |